Publication Type : Journal Article
Publisher : Springer Science and Business Media LLC
Source : European Journal of Clinical Microbiology & Infectious Diseases
Url : https://doi.org/10.1007/s10096-025-05300-8
Campus : Amritapuri
School : School of Biotechnology
Year : 2025
Abstract : The global rise in multidrug-resistant (MDR) Klebsiella pneumoniae, a critical ESKAPE pathogen, has outpaced the development of effective antibiotics. Bacteriophage therapy offers a promising alternative, but therapeutic candidates must be carefully selected for broad activity, genetic safety, synergistic cocktail performance, and clinical stability.
Cite this Research Publication : Malavika Binitha Hari, A. L. Sreelekshmi, Pradeesh Babu, Abhijith Pulimoottil Jaykumar, Sivaraj Barath, Sharayu Magar, Sutharsan Govindarajan, John Bernet Johnson, Anil Kumar, Jayalekshmi Haripriyan, Victor Nizet, Jason Gill, Lindsey Camara, Dwayne R. Roach, Bipin G. Nair, Geetha B. Kumar, Novel bacteriophages effectively target multidrug-resistant clinical isolates of Klebsiella pneumoniae, European Journal of Clinical Microbiology & Infectious Diseases, Springer Science and Business Media LLC, 2025, https://doi.org/10.1007/s10096-025-05300-8
